Dataset Information


Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation.

ABSTRACT: The graft-versus-tumor (GVT) effect after allogeneic hematopoietic cell transplantation (allo-HCT) represents an effective form of immunotherapy against many malignancies. Meaningful separation of the potentially curative GVT responses from graft-versus-host disease (GVHD), the most serious toxicity following T-cell replete allo-HCT, has been an elusive goal. GVHD is initiated by alloantigens, although both alloantigens and tumor-specific antigens (TSAs) initiate GVT responses. Emerging data have illuminated a role for antigen-presenting cells (APCs) in inducing alloantigen-specific responses. By using multiple clinically relevant murine models, we show that a specific subset of host-derived APCs-CD8(+) dendritic cells (DCs)-enhances TSA responses and is required for optimal induction of GVT. Stimulation of TLR3, which among host hematopoietic APC subsets is predominantly expressed on CD8(+) DCs, enhanced GVT without exacerbating GVHD. Thus, strategies that modulate host APC subsets without direct manipulation of donor T cells could augment GVT responses and enhance the efficacy of allo-HCT.

PROVIDER: S-EPMC3656455 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC3324629 | BioStudies
| S-EPMC6240608 | BioStudies
| S-EPMC3366405 | BioStudies
| S-EPMC5790363 | BioStudies
| S-EPMC5436544 | BioStudies
| S-EPMC3668849 | BioStudies
| S-EPMC3139384 | BioStudies
| S-EPMC3553241 | BioStudies
| S-EPMC5126092 | BioStudies
| S-EPMC7406296 | BioStudies